[A phosphorylated biguanide: benfosformin (JAV 852). II. General pharmacological properties].
D000700:Analgesics; D000779:Anesthetics, Local; D000818:Animals; D000893:Anti-Inflammatory Agents; D001341:Autonomic Nervous System / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects; D001593:Benzyl Compounds / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D001645:Biguanides / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D001794:Blood Pressure / Q000187:drug effects; D001833:Body Temperature Regulation / Q000187:drug effects; D001921:Brain / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D006224:Cricetinae; D004064:Digestive System / Q000187:drug effects; D004232:Diuretics; D004386:Duodenum / Q000187:drug effects; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D066298:In Vitro Techniques; D051379:Mice; D009943:Organophosphorus Compounds / Q000494:pharmacology / Q000633:toxicity; D011817:Rabbits; D051381:Rats; D012119:Respiration / Q000187:drug effects; D012702:Serotonin Antagonists; D013564:Sympathetic Nervous System / Q000187:drug effects; D014527:Uric Acid / Q000378:metabolism
D000700:Analgesics; D000779:Anesthetics, Local; D000893:Anti-Inflammatory Agents; D001593:Benzyl Compounds; D001645:Biguanides; D004232:Diuretics; D006634:Histamine H1 Antagonists; D009943:Organophosphorus Compounds; D012702:Serotonin Antagonists; D014527:Uric Acid; D002784:Cholesterol
Un biguanide phosphorylé: la benfosformine (JAV 852). II. Proprietés pharmacologiques Générales.